<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36054734</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns.</ArticleTitle><Pagination><StartPage>1030</StartPage><EndPage>1045</EndPage><MedlinePgn>1030-1045</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.26488</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The purpose of this study was to identify subtypes of amyotrophic lateral sclerosis (ALS) by comparing patterns of neurodegeneration using brain magnetic resonance imaging (MRI) and explore their phenotypes.</AbstractText><AbstractText Label="METHODS">We performed T1-weighted and diffusion tensor imaging in 488 clinically well-characterized patients with ALS and 338 control subjects. Measurements of whole-brain cortical thickness and white matter connectome fractional anisotropy were adjusted for disease-unrelated variation. A probabilistic network-based clustering algorithm was used to divide patients into subgroups of similar neurodegeneration patterns. Clinical characteristics and cognitive profiles were assessed for each subgroup. In total, 512 follow-up scans were used to validate clustering results longitudinally.</AbstractText><AbstractText Label="RESULTS">The clustering algorithm divided patients with ALS into 3 subgroups of 187, 163, and 138 patients. All subgroups displayed involvement of the precentral gyrus and are characterized, respectively, by (1) pure motor involvement (pure motor cluster [PM]), (2) orbitofrontal and temporal involvement (frontotemporal cluster [FT]), and (3) involvement of the posterior cingulate cortex, parietal white matter, temporal operculum, and cerebellum (cingulate-parietal-temporal cluster [CPT]). These subgroups had significantly distinct clinical profiles regarding male-to-female ratio, age at symptom onset, and frequency of bulbar symptom onset. FT and CPT revealed higher rates of cognitive impairment on the Edinburgh cognitive and behavioral ALS screen (ECAS). Longitudinally, clustering remained stable: at 90.4% of their follow-up visits, patients clustered in the same subgroup as their baseline visit.</AbstractText><AbstractText Label="INTERPRETATION">ALS can manifest itself in 3 main patterns of cerebral neurodegeneration, each associated with distinct clinical characteristics and cognitive profiles. Besides the pure motor and frontotemporal dementia (FTD)-like variants of ALS, a new neuroimaging phenotype has emerged, characterized by posterior cingulate, parietal, temporal, and cerebellar involvement. ANN NEUROL 2022;92:1030-1045.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Harold H G</ForeName><Initials>HHG</Initials><Identifier Source="ORCID">0000-0002-2981-9680</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westeneng</LastName><ForeName>Henk-Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitert</LastName><ForeName>Abram D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Veenhuijzen</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4386-2351</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Jil M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-5196-1627</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Burgh</LastName><ForeName>Hannelore K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Zandvoort</LastName><ForeName>Martine J E</ForeName><Initials>MJE</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Psychology, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Es</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, UMC Utrecht Brain Center University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>15</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36054734</ArticleId><ArticleId IdType="pmc">PMC9826424</ArticleId><ArticleId IdType="doi">10.1002/ana.26488</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet 2017;390:2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H&#x2010;J, Debray TPA, Visser AE, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 2018;17:423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol 2021;17:1&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Louwerse ES, Visser CE, Bossuyt PMM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS consortium. J Neurol Sci 1997;152:S10&#x2013;S17.</Citation><ArticleIdList><ArticleId IdType="pubmed">9419048</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population&#x2010;based cohort study. Lancet Neurol 2012;11:232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van Blitterswijk M, Huisman MHB, et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 2012;79:878&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pubmed">22843265</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HHG, Westeneng H, van der Burgh HK, et al. The distinct traits of the UNC13A polymorphism in amyotrophic lateral sclerosis. Ann Neurol 2020;88:796&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540607</ArticleId><ArticleId IdType="pubmed">32627229</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK, Westeneng HJ, Walhout R, et al. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology 2020;94:e2592&#x2013;e2604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455328</ArticleId><ArticleId IdType="pubmed">32414878</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Agosta F, Grosskreutz J, et al. Neuroimaging endpoints in amyotrophic lateral sclerosis. Neurotherapeutics 2016;14:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233627</ArticleId><ArticleId IdType="pubmed">27752938</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother 2018;18:395&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">29630421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, et al. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker LA, Schr&#xf6;der CD, Spreij LA, et al. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotroph Lateral Scler Frontotemporal Degener 2018;20:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30314420</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Jones A, Jivraj N, et al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">24720420</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, S&#xe9;gonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 2006;31:968&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S, Crain BJ, Chacko VP, van Zijl PCM. Three&#x2010;dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">9989633</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt R, Verstraete E, de Reus MA, et al. Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:4386&#x2013;4395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4207190</ArticleId><ArticleId IdType="pubmed">24604691</ArticleId></ArticleIdList></Reference><Reference><Citation>de Reus MA, van den Heuvel MP. Estimating false positives and negatives in brain networks. NeuroImage 2013;70:402&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">23296185</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren S, Groothuis&#x2010;Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw 2011;45:1&#x2013;67.</Citation></Reference><Reference><Citation>Jeub LGS, Sporns O, Fortunato S. Multiresolution consensus clustering in networks. Sci Rep 2018;8:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818657</ArticleId><ArticleId IdType="pubmed">29459635</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Carass A, He Y, Prince JL. Automatic cerebellum anatomical parcellation using U&#x2010;net with locally constrained optimization. NeuroImage 2020;218:116819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416473</ArticleId><ArticleId IdType="pubmed">32438049</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AM, Ridgway GR, Webster MA, et al. Permutation inference for the general linear model. NeuroImage 2014;92:381&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010955</ArticleId><ArticleId IdType="pubmed">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Nichols TE. Threshold&#x2010;free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009;44:83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007;68:1571&#x2013;1575.</Citation><ArticleIdList><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Kiernan MC, Heggie S, et al. Study of motor asymmetry in ALS indicates an effect of limb dominance on onset and spread of weakness, and an important role for upper motor neurons. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">24809721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitert AD, Tan HH, Walhout R, et al. Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2022;93:82&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8685620</ArticleId><ArticleId IdType="pubmed">34663622</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis &#x2010; frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:153&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55:1621&#x2013;1626.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Beeldman E, Schmand B, et al. The ALS&#x2010;FTD&#x2010;Q: a new screening tool for behavioral disturbances in ALS. Neurology 2012;79:1377&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">22972650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Schuster C, Machts J, et al. Microstructural white matter changes underlying cognitive and behavioural impairment in ALS&#x2010;&#x2010;an in vivo study using DTI. PLoS One 2014;9:e114543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263750</ArticleId><ArticleId IdType="pubmed">25501028</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenji S, Ishaque A, Mah D, et al. Neuroanatomical associations of the Edinburgh cognitive and behavioural ALS screen (ECAS). Brain Imaging Behav 2021;15:1641&#x2013;1654.</Citation><ArticleIdList><ArticleId IdType="pubmed">33155172</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Ferraro PM, Riva N, et al. Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp 2016;37:1614&#x2013;1626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6867462</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Riederer F, et al. Gray matter and white matter changes in non&#x2010;demented amyotrophic lateral sclerosis patients with or without cognitive impairment: a combined voxel&#x2010;based morphometry and tract&#x2010;based spatial statistics whole&#x2010;brain analysis. Brain Imaging Behav 2018;12:547&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">28425061</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadar M, Manera AL, Zinman L, et al. Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of TDP43. Brain Commun 2020;2:fcaa061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846188</ArticleId><ArticleId IdType="pubmed">33543125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Devenney E, Dobson&#x2010;Stone C, et al. Cerebellar integrity in the amyotrophic lateral sclerosis&#x2010;frontotemporal dementia continuum. PLoS One 2014;9:e105632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140802</ArticleId><ArticleId IdType="pubmed">25144223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Chipika RH, Christidi F, et al. Genotype&#x2010;associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro&#x2010;cerebellar connectivity alterations. J Neurol Neurosurg Psychiatry 2021;92:1197&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522463</ArticleId><ArticleId IdType="pubmed">34168085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Kril JJ, McGinley C, et al. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions. Ann Neurol 2016;79:295&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">26599997</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Sarraj S, King A, Troakes C, et al. p62 positive, TDP&#x2010;43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72&#x2010;linked FTLD and MND/ALS. Acta Neuropathol 2011;122:691&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellersen HM, Guo CC, O'callaghan C, et al. Cerebellar atrophy in neurodegeneration&#x2014;a meta&#x2010;analysis. J Neurol Neurosurg Psychiatry 2017;88:780&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501823</ArticleId></ArticleIdList></Reference><Reference><Citation>Guell X, Schmahmann J. Cerebellar functional anatomy: a didactic Summary based on human fMRI evidence. Cerebellum 2020;19:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31707620</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas Yeo BT, Krienen FM, Sepulcre J, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 2011;106:1125&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3174820</ArticleId><ArticleId IdType="pubmed">21653723</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Tu S, Dharmadasa T, et al. Apathy is associated with parietal cortical&#x2010;subcortical dysfunction in ALS. Cortex 2021;145:341&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">33867121</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, Przybelski SA, Weigand SD, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain 2009;132:2932&#x2013;2946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768663</ArticleId><ArticleId IdType="pubmed">19762452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranasinghe KG, Rankin KP, Pressman PS, et al. Distinct subtypes of behavioral&#x2010;variant frontotemporal dementia based on patterns of network degeneration. JAMA Neurol 2016;73:1078&#x2013;1088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024785</ArticleId><ArticleId IdType="pubmed">27429218</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor CM, Landin&#x2010;Romero R, Clemson L, et al. Behavioral&#x2010;variant frontotemporal dementia: distinct phenotypes with unique functional profiles. Neurology 2017;89:570&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5562953</ArticleId><ArticleId IdType="pubmed">28701492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde ALW, Byrne S, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology 2013;81:361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H&#x2010;J, Walhout R, Straathof M, et al. Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion. J Neurol Neurosurg Psychiatry 2016;87:1354&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136726</ArticleId><ArticleId IdType="pubmed">27756805</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris G, Borghero G, Di Stefano F, et al. Phenotypic variability related to C9orf72 mutation in a large Sardinian kindred. Amyotroph Lateral Scler Frontotemporal Degener 2015;17:245&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575405</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Pradat PF, Querin G, et al. Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front Neurosci 2019;13:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>